Cargando…
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
BACKGROUND: A pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, for the management of postoperative ileus after bowel resection. METHODS: Adult patients who underwent laparotomy for bowel resect...
Autores principales: | Ludwig, Kirk, Viscusi, Eugene R., Wolff, Bruce G., Delaney, Conor P., Senagore, Anthony, Techner, Lee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917559/ https://www.ncbi.nlm.nih.gov/pubmed/20526599 http://dx.doi.org/10.1007/s00268-010-0635-9 |
Ejemplares similares
-
Management of postoperative ileus: focus on alvimopan
por: Marderstein, Eric L, et al.
Publicado: (2008) -
Prevention of Paralytic Ileus Utilizing Alvimopan Following Spine Surgery
por: Shah, Kalpit N., et al.
Publicado: (2015) -
Pathogenesis and clinical and economic consequences of postoperative ileus
por: Senagore, Anthony J
Publicado: (2010) -
Delayed gastrointestinal recovery after abdominal operation – role of alvimopan
por: Berger, Nicholas G, et al.
Publicado: (2015) -
Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative Ileus
por: Leslie, John B., et al.
Publicado: (2011)